Healthcare - Sector
INBX is currently covered by 2 analysts
Inhibrx's activity chart (see below) currently has 24 price targets and 26 ratings on display. The stock rating distribution of INBX is 100% BUY.
Analysts' price targets on this stock were met 100% of the time, taking 1477 days on average.
Highest price target for INBX is $116, Lowest price target is $67.
Most recent stock forecast was given by RENI BENJAMIN from JMP on 22-Aug-2025.
Currently out of the existing stock ratings of INBX, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jul-2024
1 years 2 months 30 days ago
(22-Aug-2025)
6/6 (100%)
$27 (0.00%)
1120
Buy Since 09-Aug-2022
$46
$48
3 years 8 months 14 days ago
(07-Mar-2023)
6/6 (100%)
$46 (0.00%)
1384
Buy Since 23-Aug-2022
$45
$30
4 years 2 months 29 days ago
(23-Aug-2022)
2/2 (100%)
$45 (0.00%)
1498
$60
$30
5 years 1 months 9 days ago
(12-Oct-2021)
2/2 (100%)
$60 (0.00%)
1658
$44
$26
5 years 6 months 26 days ago
(26-Apr-2021)
2/2 (100%)
$44 (0.00%)
1725
What is INBX (Inhibrx) average time for price targets to be met?
Which analyst most recently updated their price target on INBX (Inhibrx)?
Which analyst has the lowest performance score on INBX (Inhibrx) with a proven track record?
Which analyst has the most public recommendations on INBX (Inhibrx)?
Which analyst is the currently most bullish on INBX (Inhibrx)?
Which analyst is the currently most reserved on INBX (Inhibrx)?